A Double-Blind Discontinuation Study of Levetiracetam in Post- Traumatic Stress Disorder.
Phase of Trial: Phase II/III
Latest Information Update: 30 Oct 2014
At a glance
- Drugs Levetiracetam (Primary)
- Indications Post-traumatic stress disorders
- Focus Therapeutic Use
- 13 Aug 2008 Actual end date is now 1 March 2008 as reported by ClinicalTrials.gov.
- 13 Aug 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 13 Aug 2008 Actual patient number is 16 as reported by ClinicalTrials.gov.